<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain><z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease is a systemic condition of unknown cause characterized in 20 to 40% of cases by venous and/or <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> that is not fully explained by the hemostasis disorders reported in the literature </plain></SENT>
<SENT sid="1" pm="."><plain>The present study investigated resistance to activated protein C in 65 Behçet's disease patients, 75 <z:mpath ids='MPATH_458'>normal</z:mpath> subjects, and 70 patients with a history of isolated <z:mp ids='MP_0005048'>thrombosis</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The test used involved predilution in factor V-deficient plasma </plain></SENT>
<SENT sid="3" pm="."><plain>Activated protein C resistance was found in six <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease patients (9.2%), eight <z:mpath ids='MPATH_458'>normal</z:mpath> subjects (10.6%), and 21 patients with isolated <z:mp ids='MP_0005048'>thrombosis</z:mp> (30%) </plain></SENT>
<SENT sid="4" pm="."><plain>Of the 26 Behçet's disease patients (40%) with a history of <z:mp ids='MP_0005048'>thrombosis</z:mp>, only one had activated protein C resistance </plain></SENT>
<SENT sid="5" pm="."><plain>Activated protein C resistance does not explain the increased risk of <z:mp ids='MP_0005048'>thrombosis</z:mp> in <z:chebi fb="6" ids="22696">Beh</z:chebi>çet's disease patients </plain></SENT>
</text></document>